481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors

• Michael Manos,
• Patrick Ott,
• Anita Giobbie-Hurder,
• Osama Rahma,
• Nicole LeBoeuf,
• Kevin Tyan,
• Ai-Tram Bui,
• Isaac Klein,
• Leyre Zubiri,
• Kerry Reynolds,
• Shilpa Grover,
• Gerald Weinhouse

Affiliations

Michael Manos

2Dana-Farber Cancer Institute, Boston, MA, USA

Patrick Ott

2Dana-Farber Cancer Institute, Boston, MA, USA

Anita Giobbie-Hurder

2Dana-Farber Cancer Institute, Boston, MA, USA

Osama Rahma

2Dana-Farber Cancer Institute, Boston, MA, USA

Nicole LeBoeuf

4Brigham and Women’s Hospital, Bostom, MA, USA

Kevin Tyan

1Harvard Medical School, Somerville, MA, USA

Ai-Tram Bui

1Harvard Medical School, Somerville, MA, USA

Isaac Klein

2Dana-Farber Cancer Institute, Boston, MA, USA

Leyre Zubiri

3Massachusetts General Hospital, Boston, MA, USA

Kerry Reynolds

3Massachusetts General Hospital, Boston, MA, USA

Shilpa Grover

4Brigham and Women’s Hospital, Bostom, MA, USA

Gerald Weinhouse

4Brigham and Women’s Hospital, Bostom, MA, USA